Subtype-specific genomic alterations define new targets for soft tissue sarcoma therapy
2011 February 1
Main Authors: | Lander, Eric S., Meyerson, Matthew L. |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Language: | en_US |
Published: |
Nature Publishing Group
2012
|
Online Access: | http://hdl.handle.net/1721.1/74034 |
Similar Items
-
Isoform-specific deletion of PKM2 constrains tumor initiation in a mouse model of soft tissue sarcoma
by: Dayton, Talya L., et al.
Published: (2018) -
Expressions of angiogenic markers and apoptotic markers in soft tissue sarcoma
by: Yusuf, Yusri
Published: (2010) -
Oxidative stress and antioxidant status in primary bone and soft tissue sarcoma
by: Nathan, F.M., et al.
Published: (2011) -
Defining the core essential genome of Pseudomonas aeruginosa
by: Lander, Eric S.
Published: (2020) -
Mucoepidermoid carcinoma mimicking a soft tissue sarcoma: a case report
by: Sandhu, S.S., et al.
Published: (2007)